Eliem Therapeutics, Inc. (ELYM)

5.11 (USD) • At close October 2, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024	2023	2022	2021	2020	2019
Revenue Numbers are in millions	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0	0	0	0	0
Gross Profit Numbers are in millions	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	14.176	15.411	26.214	23.322	9.342	4.019
General & Administrative Expenses Numbers are in millions	16.025	9.888	18.921	12.35	2.425	0.677
Selling & Marketing Expenses Numbers are in millions	0	24.854	0	0	0	0
SG&A Numbers are in millions	16.025	9.888	18.921	12.35	2.425	0.677
Other Expenses Numbers are in millions	51.819	0	1.375	-11.638	0	0.914
Operating Expenses Numbers are in millions	82.02	37.408	45.135	35.672	11.767	4.696
Operating Income Numbers are in millions	-82.02	-21.466	-45.135	-35.672	-20.925	-7.446
Operating Income Ratio Numbers are in millions	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	8.123	-13.653	-0.109	-11.808	0.257	0.899
Income Before Tax Numbers are in millions	-73.897	-35.119	-45.244	-47.48	-20.668	-6.547
Income Before Tax Ratio Numbers are in millions	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	-0.021	0.109	-0.067	-9.158	-2.75
Net Income Numbers are in millions	-73.897	-35.119	-45.353	-47.48	-11.51	-3.797
Net Income Ratio Numbers are in millions	0	0	0	0	0	0
EPS Numbers are in millions	-1.53	-1.3	-1.72	-1.81	-0.44	-0.14
EPS Diluted Numbers are in millions	-1.53	-1.3	-1.72	-1.81	-0.44	-0.14
EBITDA Numbers are in millions	-82.02	-13.653	-43.651	-35.502	-2.866	-1.931
EBITDA Ratio Numbers are in millions	0	0	0	0	0	0

Eliem Therapeutics, Inc.